Northern Trust’s Firefly Neuroscience AIFF Stock Holding History

Northern Trust’s Portfolio AIFF Stock Details AIFF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40.5K	Buy	33,494 +17,730	+112%	+$30.9K	﹤0.01%	4297
2026 Q1	$34.4K	Hold	15,764	–	–	﹤0.01%	4291
2025 Q4	$13.8K	Buy	15,764 +396	+3%	+$738	﹤0.01%	4417
2025 Q3	$44.7K	Hold	15,368	–	–	﹤0.01%	4294
2025 Q2	$43.5K	Hold	15,368	–	–	﹤0.01%	4252
2025 Q1	$60.4K	Buy	+15,368	New	+$70.7K	﹤0.01%	4203
2023 Q4	–	Sell	-614	Closed	-$4.76K	–	4558
2023 Q3	$4.76K	Hold	614	–	–	﹤0.01%	4437
2023 Q2	$5.62K	Hold	614	–	–	﹤0.01%	4510
2023 Q1	$5.33K	Hold	614	–	–	﹤0.01%	4563
2022 Q4	$8.84K	Hold	614	–	–	﹤0.01%	4585
2022 Q3	$18K	Hold	614	–	–	﹤0.01%	4565
2022 Q2	$25K	Hold	614	–	–	﹤0.01%	4589
2022 Q1	$97K	Buy	+614	New	+$83K	﹤0.01%	4349

Other funds holding AIFF

Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCA

Cygnus Capital Advisors Atlanta, Georgia $147M AUM

Northern Trust's AIFF Position: Q2 2026 in Review

Northern Trust increased its Firefly Neuroscience (AIFF) stake by 112% in Q2 2026, buying an estimated $30.9K and bringing the position to 33,494 shares worth $40.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4297.

Northern Trust first reported a position in AIFF in Q1 2022 and has held it in 13 quarters since. The position peaked at $97K in Q1 2022. 23 funds tracked by Wall St. Rank hold AIFF as of Q2 2026.

Northern Trust held 33,494 shares of Firefly Neuroscience worth $40.5K as of Q2 2026.
Northern Trust bought 17,730 Firefly Neuroscience shares in Q2 2026, an estimated $30.9K.
Firefly Neuroscience made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4297 holding.
Northern Trust first reported a position in Firefly Neuroscience in Q1 2022 and has held it in 13 quarters since.
Northern Trust's Firefly Neuroscience position peaked at $97K in Q1 2022.
23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.